NBP – novabridge biosciences - american depositary shares (US:NASDAQ)
Stock Stats
News
NovaBridge Appoints Biotech Leader, Emmett T. Cunningham, Jr, MD, PhD, MPH, as Vice Chairman of the Board to Further Accelerate Global Biotech Platform
NovaBridge Doses First Patient in Global, Randomized Phase 2 Study of Givastomig Combined with Immunochemotherapy in Patients with 1L Metastatic Gastric Cancer
I-Mab (NASDAQ:NBP) is now covered by analysts at Weiss Ratings. They set a "sell (d-)" rating on the stock.
I-Mab (NASDAQ:NBP) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $9.00 price target on the stock.
NovaBridge Announces Open Market Purchases by Executive Chairman, Fu Wei
Form 6-K NovaBridge Biosciences For: Feb 19
Form 6-K NovaBridge Biosciences For: Feb 17
Form 6-K/A NovaBridge Biosciences For: Feb 06
Form 6-K NovaBridge Biosciences For: Feb 06
Form SCHEDULE 13D/A NovaBridge Biosciences Filed by: CBC Investment I-Mab Ltd
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.